← Back to Search

Corticosteroid

Dexamethasone 4 mg for Diabetes (CSI Trial)

Phase 2
Recruiting
Led By Anthony Ceraulo, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 weeks, 6 weeks, 3 months
Awards & highlights

CSI Trial Summary

This trial is measuring the effect of corticosteroids on blood sugar and pain scores in diabetic patients with shoulder pain.

Eligible Conditions
  • Diabetes
  • Shoulder Pain

CSI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 weeks, 6 weeks, 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 weeks, 6 weeks, 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in blood glucose measures
Secondary outcome measures
Change in patient reported outcomes

CSI Trial Design

4Treatment groups
Active Control
Group I: Dexamethasone 4 mgActive Control1 Intervention
Thirty-one subjects will be randomized to this arm. Each subject randomized to this arm will receive one 4 mg corticosteroid injection of Dexamethasone in the index shoulder.
Group II: Depo-medrol 40 mgActive Control1 Intervention
Thirty-one subjects will be randomized to this arm. Each subject randomized to this arm will receive one 40 mg corticosteroid injection of Depo-Medrol in the index shoulder.
Group III: Celestone 6 mgActive Control1 Intervention
Thirty-one subjects will be randomized to this arm. Each subject randomized to this arm will receive one 6 mg corticosteroid injection of Celestone in the index shoulder.
Group IV: Kenalog 40 mgActive Control1 Intervention
Thirty-one subjects will be randomized to this arm. Each subject randomized to this arm will receive one 40 mg corticosteroid injection of Kenalog in the index shoulder.

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,359 Previous Clinical Trials
3,420,167 Total Patients Enrolled
14 Trials studying Diabetes
35,560 Patients Enrolled for Diabetes
Anthony Ceraulo, MDPrincipal InvestigatorDuke University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any current opportunities to join this medical experiment?

"This medical trial is not accepting patients as of now, with the most recent edit to its posting being on 11/11/2022. If you are still searching for a study to join, there are 1237 open clinical trials concerning shoulder pain and another 728 studies actively recruiting participants looking into Depo-medrol 40 mg."

Answered by AI

What potential dangers should be taken into account when administering Depo-medrol 40 mg?

"Although there is some data that suggests Depo-medrol 40 mg is safe, since this trial is Phase 2 the safety rating was set at a conservative 2."

Answered by AI

What prior examinations have been conducted with Depo-medrol 40 mg?

"At this point in time, a total of 728 clinical trials are researching the effects of Depo-medrol 40 mg. Of those studies, 186 have reached Phase 3 and mainly take place in Minneapolis, Minnesota. However, there are 23577 locations worldwide running similar tests for the same drug."

Answered by AI

Does this research protocol accommodate participants younger than twenty years of age?

"In accordance with the criteria for inclusion, the lower limit of age is 40 and the upperbound is 75."

Answered by AI

What conditions can be ameliorated by Depo-medrol 40 mg?

"Depo-medrol 40 mg is a viable option for managing macular edema, ophthalmic issues, and ulcerative colitis."

Answered by AI

How many participants have volunteered for this research endeavor?

"At present, the study is not recruiting patients. Initially published on December 5th 2022 and last revised November 11th 2022; however, there are 1237 other studies that focus on shoulder pain and 728 trials for Depo-medrol 40 mg admitting participants right now."

Answered by AI

Are the criteria for participation in this research project consistent with my profile?

"A total of 124 participants aged between 40 and 75 that suffer from shoulder pain are required for this trial. Additionally, all potential volunteers must be able to both receive and send text messages on their device."

Answered by AI
~16 spots leftby Oct 2024